Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  liposomal cytarabine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-14 of 14 for your search:
Start Over
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SKY0101-010, NCT00029523
Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: GMALL06, NCT00199108
Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: NILG-ALL 10/07, NCT00795756
Phase III Randomized Study of DepoFoam-Encapsulated Cytarabine (DTC 101) vs Standard Intrathecal Therapy for Neoplastic Meningitis (Summary Last Modified 08/95)
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-94129, NCI-V95-0661
Phase III Study of Liposomal Cytarabine Versus Standard Therapy for Neoplastic Meningitis in Patients With Leukemia, Lymphoma, or Solid Tumors (Summary Last Modified 09/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DTC-92-001, NCI-V97-1338
Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)
Phase: Phase III
Type: Treatment
Status: Temporarily closed
Age: 1 to 18
Sponsor: Other
Protocol IDs: NOPHOALL2008-DepoCyte, NCT00991744
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 6 months to under 21 at relapse
Sponsor: NCI
Protocol IDs: NCI-2012-01528, POG-9412, CDR0000064509, NCT00002704
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-048, U01CA070019, CDR0000510918, NCT00392834
Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2004-004414-17, DEPOCYLAN, NCT00388531
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6954, NCI-2009-01309, P30CA015704, NCT00992602
Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
Phase: Phase I
Type: Treatment
Status: Closed
Age: 1 to 21
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000065754, SKYEPHARMA-96-002, DTC-96-002, NCI-V97-1336, NCT00003073
Start Over